Gadoxetic Acid-Enhanced MRI-Based Radiomics Signature: A Potential Imaging Biomarker for Identifying Cytokeratin 19-Positive Hepatocellular Carcinoma

<div>Representative images of different phases of gadoxetic acid-enhanced MRI and CK19 status by immunohistochemical staining (CK19 negative (a–d); CK19 positive (e–h)).</div>

Computational and Mathematical Methods in Medicine

fig3

Figure 3

Figure 3: Gadoxetic Acid-Enhanced MRI-Based Radiomics Signature: A Potential Imaging Biomarker for Identifying Cytokeratin 19-Positive Hepatocellular Carcinoma 

Figure 3 | Gadoxetic Acid-Enhanced MRI-Based Radiomics Signature: A Potential Imaging Biomarker for Identifying Cytokeratin 19-Positive Hepatocellular Carcinoma 